Craving and illicit heroin use among patients in heroin-assisted treatment

Drug and Alcohol Dependence

Volumn 120, Issue 1-3, 2012, Pages 74-80

  Blanken, Peter ^a,b   Hendriks, Vincent M ^a,b   Koeter, Maarten W J ^d   van Ree, Jan M ^a,c   van den Brink, Wim ^a,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b PARNASSIA BAVO GROEP   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Heroin craving; Heroin dependence; Heroin assisted treatment; Illicit heroin use; Methadone maintenance treatment

Indexed keywords

DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; FEMALE; HEALTH CARE AVAILABILITY; HEROIN ASSISTED TREATMENT; HEROIN DEPENDENCE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; NETHERLANDS; OBSESSIVE COMPULSIVE DRUG USE SCALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PARALLEL DESIGN; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; SELF REPORT; TREATMENT DURATION; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; PATIENT COMPLIANCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84155165451     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.06.025     Document Type: Article

References (43)

1. Anton R.F., Moak D.H., Latham P.K. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch. Gen. Psychiatry 1996, 53:225-231.
2. Blanken P., van den Brink W., Hendriks V.M., Huijsman I.A., Klous M.G., Rook E.J., Wakelin J.S., Barendrecht C., Beijnen J.H., van Ree J.M. Heroin-assisted treatment in the Netherlands: history, findings, and international context. Eur. Neuropsychopharmacol. 2010, 20:S105-S158.
3. Carter B.L., Tiffany S.T. Meta-analysis of cue-reactivity in addiction research. Addiction 1999, 94:327-340.
4. Central Committee on the Treatment of Heroin Addicts (CCBH), 2002. Medical Co-prescription of Heroin: Two Randomized Controlled Trials. Central Committee on the Treatment of Heroin Addicts, Utrecht, The Netherlands.
5. de Wildt W.A., Lehert P., Schippers G.M., Nakovics H., Mann K., van den Brink W. Investigating the structure of craving using structural equation modeling in analysis of the obsessive-compulsive drinking scale: a multinational study. Alcohol. Clin. Exp. Res. 2005, 29:509-516.
6. de Wildt W.A.J.M., Lehert P., Schippers G.M., van den Brink W. Improving the predictive value of subjective craving on relapse in alcohol dependent patients by repeated measures. Alcohol Dependence: Treatment Effectiveness and the Concept of Craving 2010, 79-92. Uitgeverij BOXPress, Oisterwijk, The Netherlands. W.A.J.M. de Wildt (Ed.).
7. Derogatis L.R. SCL-90-R: Administration, Scoring and Procedures. Manual II 1983, Clinical Psychometric Research, Towson, MD.
8. Epstein D.H., Willner-Reid J., Vahabzadeh M., Mezghanni M., Lin J.L., Preston K.L. Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch. Gen. Psychiatry 2009, 66:88-94.
9. Eysenck S.B., Eysenck H.J. An improved short questionnaire for the measurement of extraversion and neurotocism. Life Sci. 1964, 3:1103-1109.
10. Fareed A., Vayalapalli S., Casarella J., Amar R., Drexler K. Heroin anticraving medications: a systematic review. Am. J. Drug Alcohol Abuse 2010, 36:332-341.
11. Fareed A., Vayalapalli S., Stout S., Casarella J., Drexler K., Bailey S.P. Effect of methadone maintenance treatment on heroin craving, a literature review. J. Addict. Dis. 2011, 30:27-38.
12. Faupel C.E. Drug availability, life structure, and situational ethics of heroin addicts. Urban Life 1987, 15:395-419.
13. Ferri M., Davoli M., Perucci C.A. Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database Syst. Rev. 2010, 8:CD003410.
14. Field M., Cox W.M. Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug Alcohol Depend. 2008, 97:1-20.
15. Fischer B., Oviedo-Joekes E., Blanken P., Haasen C., Rehm J., Schechter M.T., Strang J., van den Brink W. Heroin-assisted treatment (HAT) a decade ater: a brief update on science and politics. J. Urban Health 2007, 84:552-562.
16. Franken I.H. Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:563-579.
17. Franken I.H., Hendriks V.M., van den Brink W. Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict. Behav. 2002, 27:675-685.
18. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159:1642-1652.
19. Haasen C., Verthein U., Degkwitz P., Berger J., Krausz M., Naber D. Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br. J. Psychiatry 2007, 191:55-62.
20. Hendriks V.M., van den Brink W., Blanken P., Bosman I.J., van Ree J.M. Heroin self-administration by means of 'chasing the dragon': pharmacodynamics and bioavailability of inhaled heroin. Eur. Neuropsychopharmacol. 2001, 11:241-252.
21. Kokkevi A., Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur. Addict. Res. 1995, 1:208-210.
22. Langleben D.D., Ruparel K., Elman I., Busch-Winokur S., Pratiwadi R., Loughead J., O'Brien C.P., Childress A.R. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am. J. Psychiatry 2008, 165:390-394.
23. Lubman D.I., Yucel M., Kettle J.W., Scaffidi A., Mackenzie T., Simmons J.G., Allen N.B. Responsiveness to drug cues and natural rewards in opiate addiction: associations with later heroin use. Arch. Gen. Psychiatry 2009, 66:205-212.
24. March J.C., Oviedo-Joekes E., Perea-Milla E., Carrasco F. Controlled trial of prescribed heroin in the treatment of opioid addiction. J. Subst. Abuse Treat. 2006, 31:203-211.
25. Marissen M.A., Franken I.H., Blanken P., Hendriks V.M., van den Brink W. The relation between social desirability and different measures of heroin craving. J. Addict. Dis. 2005, 24:91-103.
26. Marissen M.A., Franken I.H., Blanken P., van den Brink W., Hendriks V.M. Cue exposure therapy for the treatment of opiate addiction: results of a randomized controlled clinical trial. Psychother. Psychosom. 2007, 76:97-105.
27. Marsden J., Gossop M., Stewart D., Best D., Farrell M., Lehmann P., Edwards C., Strang J. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 1998, 93:1857-1867.
28. O'Brien C. Addiction and dependence in DSM-V. Addiction 2011, 106:866-867.
29. Oviedo-Joekes E., Brissette S., Marsh D.C., Lauzon P., Guh D., Anis A., Schechter M.T. Diacetylmorphine versus methadone for the treatment of opioid addiction. N. Engl. J. Med. 2009, 361:777-786.
30. Perneger T.V., Giner F., del Rio M., Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998, 317:13-18.
31. Preston, K.L., Epstein, D.H., 2011. Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology (Berl.). Epub ahead of print PMID: 21336579.
32. Rehm J., Gschwend P., Steffen T., Gutzwiller F., Dobler-Mikola A., Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001, 358:1417-1423.
33. Romo N., Poo M., Ballesta R. From illegal poison to legal medicine: a qualitative research in a heroin-prescription trial in Spain. Drug Alcohol Rev. 2009, 28:186-195.
34. Rook E.J., van Ree J.M., van den Brink W., Hillebrand M.J.X., Huitema A.D.R., Hendriks V.M., Beijnen J.H. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic Clin. Pharmacol. Toxicol. 2006, 98:86-96.
35. Sanderman R., Arrindell W.A., Ranchor A.V., Eysenck H.J., Eysenck S.B.G. Eysenck Personality Questionnaire (EPQ). Noordelijk Centrum voor Gezondheidsvraagstukken 1991, Groningen, The Netherlands.
36. Sayette M.A., Shiffman S., Tiffany S.T., Niaura R.S., Martin C.S., Shadel W.G. The measurement of drug craving. Addiction 2000, 95:S189-S210.
37. Strang J., Metrebian N., Lintzeris N., Potts L., Carnwath T., Mayet S., Williams H., Zador D., Evers R., Groshkova T., Charles V., Martin A., Forzisi L. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Lancet 2010, 375:1885-1895.
38. Tiffany S.T. A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol. Rev. 1990, 97:147-168.
39. Tiffany S.T., Carter B.L. Is craving the source of compulsive drug use?. J. Psychopharmacol. 1998, 12:23-30.
40. Tiffany S.T., Conklin C.A. A cognitive processing model of alcohol craving and compulsive alcohol use. Addiction 2000, 95(Suppl. 2):S145-S153.
41. Van den Brink W., Hendriks V.M., Blanken P., Koeter M.W., van Zwieten B.J., van Ree J.M. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 2003, 327:310-312.
42. Verheul R., Van den Brink W., Geerlings P. A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol. 1999, 34:197-222.
43. Zinberg N.E. Drug, Set, and Setting: The Basis for Controlled Intoxicant Use 1984, Yale University Press, New Haven.